Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

oral boards > AHA: MR > Flashcards

AHA: MR Flashcards

1
Q

bp v mech

class 1 recommendation(s) for mitral valve choice

A
  • shared decision-making (1)
  • bp if warfarin contraindicated (1)

“For patients who require heart valve replacement, the choice of prosthetic valve should be based on a shared decision-making process that accounts for the patient’s values and preferences and includes discussion of the indications for and risks of anticoagulant therapy and the potential need for and risks associated with valve reintervention.”
“For patients of any age requiring valve replacement for whom anticoagulant therapy is contraindicated, cannot be managed appropriately, or is not desired, a bioprosthetic valve is recommended.”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

bp v mech

class 1 recommendation(s) for mitral valve choice

(2)

A
  • shared decision-making (1)
  • bp if warfarin contraindicated (1)

“For patients who require heart valve replacement, the choice of prosthetic valve should be based on a shared decision-making process that accounts for the patient’s values and preferences and includes discussion of the indications for and risks of anticoagulant therapy and the potential need for and risks associated with valve reintervention.”
“For patients of any age requiring valve replacement for whom anticoagulant therapy is contraindicated, cannot be managed appropriately, or is not desired, a bioprosthetic valve is recommended.”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

bp v mech

age-based recommendation(s) for mitral valve choice

A
  • <65yo = mech (2a)
  • ≥65yo = bp (2a)

assuming no contraindication to warfarin

“For patients <65 years of age who have an indication for MVR, do not have a contraindication to anticoagulation, and are unable to undergo MVRx, it is reasonable to choose a mechanical prosthesis over a bioprosthetic valve.”
“For patients ≥65 years of age who require MVR and are unable to undergo MVRx, it is reasonable to choose a bioprosthesis over a mechanical valve.”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

bp v mech

mitral valve choice if warfarin contraindicated

A

bp (1)

“For patients who require heart valve replacement, the choice of prosthetic valve should be based on a shared decision-making process that accounts for the patient’s values and preferences and includes discussion of the indications for and risks of anticoagulant therapy and the potential need for and risks associated with valve reintervention.”
“For patients of any age requiring valve replacement for whom anticoagulant therapy is contraindicated, cannot be managed appropriately, or is not desired, a bioprosthetic valve is recommended.”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

bp v mech

mitral valve choice in <65yo

assuming no contraindication to warfarin

A

mech
(2a)

“For patients <65 years of age who have an indication for MVR, do not have a contraindication to anticoagulation, and are unable to undergo MVRx, it is reasonable to choose a mechanical prosthesis over a bioprosthetic valve.”
“For patients ≥65 years of age who require MVR and are unable to undergo MVRx, it is reasonable to choose a bioprosthesis over a mechanical valve.”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

bp v mech

mitral valve choice in ≥65yo

assuming no contraindication to warfarin

A

bp
(2a)

“For patients <65 years of age who have an indication for MVR, do not have a contraindication to anticoagulation, and are unable to undergo MVRx, it is reasonable to choose a mechanical prosthesis over a bioprosthetic valve.”
“For patients ≥65 years of age who require MVR and are unable to undergo MVRx, it is reasonable to choose a bioprosthesis over a mechanical valve.”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

regurgitant jet width (% of LA) in mild MR

A

<20

%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

vena contracta in mild MR

A

<0.3

cm

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

RVol/Vregurg in mild MR

regurgitant volume

A

<30

mL/beat

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

RF in mild MR

regurgitant fraction

A

<30

%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

EROA in mild MR

effective regurgitant orifice area

A

<0.2

cm2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

grade in mild MR

A

1+

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

PV flow reversal in mild MR

A

systolic dominance

only specified in ASE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

regurgitant jet width (% of LA) in moderate MR

A

20-40

%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

vena contracta in moderate MR

A

0.3-0.7

cm

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

RVol/Vregurg in moderate MR

regurgitant volume

A

30-60

mL/beat

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

RF in moderate MR

regurgitant fraction

A

30-50

%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

EROA in moderate MR

effective regurgitant orifice area

A

0.2-0.4

cm2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

grade in moderate MR

A

2+

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

PV flow reversal in moderate MR

A

systolic blunting

only specified in ASE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

regurgitant jet width (% of LA) in severe MR

A

>40

%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

vena contracta in severe MR

A

≥0.7

cm

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

RVol/Vregurg in severe MR

regurgitant volume

A

≥60

mL/beat

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

RF in severe MR

regurgitant fraction

A

≥50

%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

EROA in severe MR

effective regurgitant orifice area

A

≥0.4

cm2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

grade in severe MR

A

3-4+

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

PV flow reversal in severe MR

A

holosystolic

only specified in ASE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

mitral valve

regurgitant jet width (% of LA) <20 %

29
Q

mitral valve

vena contracta <0.3 cm

30
Q

mitral valve

RVol/Vregurg <30 mL/beat

regurgitant volume

31
Q

mitral valve

RF <30 %

regurgitant fraction

32
Q

mitral valve

EROA <0.2 cm2

effective regurgitant orifice area

33
Q

mitral valve

1+ grade regurg

34
Q

mitral valve

regurgitant jet width (% of LA) = 20-40 %

A

moderate MR

35
Q

mitral valve

vena contracta = 0.3-0.7 cm

A

moderate MR

36
Q

mitral valve

RVol/Vregurg = 30-60 mL/beat

regurgitant volume

A

moderate MR

37
Q

mitral valve

RF = 30-50 %

regurgitant fraction

A

moderate MR

38
Q

mitral valve

EROA = 0.2-0.4 cm2

effective regurgitant orifice area

A

moderate MR

39
Q

mitral valve

2+ grade regurg

A

moderate MR

40
Q

mitral valve

regurgitant jet width (% of LA) >40 %

41
Q

mitral valve

vena contracta ≥0.7 cm

42
Q

mitral valve

RVol/Vregurg ≥60 mL/beat

regurgitant volume

43
Q

mitral valve

RF ≥50 %

regurgitant fraction

44
Q

mitral valve

EROA ≥0.4 cm2

effective regurgitant orifice area

45
Q

mitral valve

3-4+ grade regurg

46
Q

indication(s) for intervention in moderate 1° MR

A

NONE
regardless of sx status

47
Q

indication(s) for intervention in moderate 2° MR

A

NONE
regardless of sx status

48
Q

indication(s) for intervention in moderate MR

A

NONE
regardless of sx status

neither 1° nor 2°

49
Q

indication(s) for intervention in severe 2° MR

A
  • concomitant CABG ⇒ MVR/x (2a)
    regardless of sx status
  • sx (NYHA ≥II) ⊕GDMT + MR r/t LVEF<50% AND EF>20% + LVESD≤70mm + PASP≤70mmHg ⇒ TEER (2a)
  • v sx (NYHA ≥III) ⊕GDMT + MR r/t LVEF<50% ⇒ MVR/x (2b)
  • v sx (NYHA ≥III) ⊕GDMT + MR r/t LA annular dil + LVEF≥50% ⇒ MVR/x (2b)
50
Q

indication(s) for intervention in sx severe 2° MR

A
  • concomitant CABG ⇒ MVR/x (2a)
    regardless of sx status
  • sx (NYHA ≥II) ⊕GDMT + MR r/t LVEF<50% AND EF>20% + LVESD≤70mm + PASP≤70mmHg ⇒ TEER (2a)
  • v sx (NYHA ≥III) ⊕GDMT + MR r/t LVEF<50% ⇒ MVR/x (2b)
  • v sx (NYHA ≥III) ⊕GDMT + MR r/t LA annular dil + LVEF≥50% ⇒ MVR/x (2b)
51
Q

indication(s) for intervention in sx severe 2° MR

(4)

A
  • concomitant CABG ⇒ MVR/x (2a)
    regardless of sx status
  • sx (NYHA ≥II) ⊕GDMT + MR r/t LVEF<50% AND EF>20% + LVESD≤70mm + PASP≤70mmHg ⇒ TEER (2a)
  • v sx (NYHA ≥III) ⊕GDMT + MR r/t LVEF<50% ⇒ MVR/x (2b)
  • v sx (NYHA ≥III) ⊕GDMT + MR r/t LA annular dil + LVEF≥50% ⇒ MVR/x (2b)
52
Q

indication(s) for intervention in asx severe 2° MR

A
  • concomitant CABG ⇒ MVR/x (2a)
    regardless of sx status
53
Q

ONLY indication for intervention in asx severe 2° MR

A
  • concomitant CABG ⇒ MVR/x (2a)
    regardless of sx status
54
Q

indication(s) for surgical intervention in sx severe 2° MR

A
  • concomitant CABG ⇒ MVR/x (2a)
    regardless of sx status
  • v sx (NYHA ≥III) ⊕GDMT + MR r/t LVEF<50% ⇒ MVR/x (2b)
  • v sx (NYHA ≥III) ⊕GDMT + MR r/t LA annular dil + LVEF≥50% ⇒ MVR/x (2b)
55
Q

indication(s) for surgical intervention in sx severe 2° MR

(3)

A
  • concomitant CABG ⇒ MVR/x (2a)
    regardless of sx status
  • v sx (NYHA ≥III) ⊕GDMT + MR r/t LVEF<50% ⇒ MVR/x (2b)
  • v sx (NYHA ≥III) ⊕GDMT + MR r/t LA annular dil + LVEF≥50% ⇒ MVR/x (2b)
56
Q

indication(s) for transcatheter intervention in sx severe 2° MR

A
  • sx (NYHA ≥II) ⊕GDMT + MR r/t LVEF<50% AND EF>20% + LVESD≤70mm + PASP≤70mmHg ⇒ TEER (2a)
57
Q

indication(s) for transcatheter intervention in sx severe 2° MR

(1)

A
  • sx (NYHA ≥II) ⊕GDMT + MR r/t LVEF<50% AND EF>20% + LVESD≤70mm + PASP≤70mmHg ⇒ TEER (2a)
58
Q

preferred surgical intervention in 2° MR

A

chordal-sparing MVR (>MVRx)
(2b)

59
Q

preferred surgical intervention in 1° MR

A

MVRx (>MVR) in degen dz
(1)

60
Q

indication(s) for intervention in severe 1° MR

A
  • sx (regardless of EF) (1)
  • v sx (NYHA ≥III) + high/prohib-risk ⇒ TEER (2a)
  • rheumatic etio & rx likely @ CVC ⇒ MVR/x (2b)
  • asx + LV dysfxn (EF≤60% OR LVESD≥40mm) (1)
  • asx + EF=WNL AND >95% rx & <1% mort @ CVC (2a)
  • asx + EF=WNL BUT progressive ￬ EF OR ↑ LVESD on 3 studies (2b)
61
Q

CTSNet severe ischemic MR trial: primary endpoint

A

LVESD volume index (i.e. LV remodeling)
⇒∅

62
Q

CTSNet severe ischemic MR trial: outcomes

A

￬HF SAEs (incl re-adm) & ￬mod+MR with replacement

63
Q

2° severe MR feature/anatomy most predictive of recurrent MR after MVRx

A

basal inferior dyskinesis
(in post-hoc analysis of CTSNet severe MR trial; SESATS)

64
Q

preferred ring/band choice for a MVRx for 2° MR

A

complete (slightly undersized) ring
(still semi-rigid?)

65
Q

pulmonary edema laterality 2/2 mitral dz

A

R
2/2 flow reversal into PVs during systole, with relative obstr to R-sided pulm venous return, with retrograde increase in hydrostatic pressure

66
Q

mgmt of acute MR 2/2 chordal rupture

A

emergent MVRx (usu not 2/2 MI)

67
Q

unilateral R pulm edema, fever, leukocytosis, acute onset, +systolic murmur

A

acute MR 2/2 chordal rupture

68
Q

Where & what structures are at risk around the mitral annulus?

A
  1. LCx @ P1 > anterolat commissure
  2. NCC @ anterior leaflet (A3)
    (>>LCC@A1)
  3. coronary sinus @ posterior leaflet P3>P2
  • ± bundle of His @ A3/posteromed commissure (next to R trigone in membranous septum)
69
Q

What are the 2 papillary muscles and their blood supply?

A
  1. anterolateral = LAD + LCx
  2. posteromedial = RCA (PDA)

oral boards (15 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2025 Bold Learning Solutions. Terms and Conditions